Will ResMed Inc. Shares Fly Above $50?

While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.

What: Shares of ResMed (NYSE: RMD  ) gained about 1% today after the medical equipment company posted strong quarterly results and received a hold-to-buy upgrade from Deutsche Bank.

So what: Along with the upgrade, analyst David Low raised his price target to $52 (from $48), representing about 11% worth of upside to yesterday's close. So while momentum traders might be turned off by ResMed's sharp pullback over the past six months, Low's call could reflect a growing sense on Wall Street that its long-term growth potential is becoming too cheap to pass up.

Now what: According to Deutsche, ResMed's risk/reward trade-off is particularly attractive at this point. "While the risk of further price pressure cannot be ruled out we believe a return to more normal pricing and demand conditions is likely post CB2 and ResMed's sales growth in FY15 will be boosted by its new product range and its move into non-invasive ventilation in the US," said Low. "The key risk to our thesis is the potential for further funding reforms (i.e. bundled pricing) but such a change would take a number of years to introduce (assuming private payors follow CMS) and in the interim the market should continue to grow given the positive secular trends." When you couple that upbeat outlook with ResMed's still-reasonable PEG of 1.3, it's tough to disagree with Deutsche's bullishness. 

6 stock picks poised for incredible growth
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2929052, ~/Articles/ArticleHandler.aspx, 9/5/2015 6:38:49 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Brian Pacampara

I take a look at big 10% moves, as well as stock-shaking analyst calls, on a daily basis for The Fool. While I don't believe in active trading, closely monitoring Mr. Market's mood swings can help identify long-term opportunities.

Today's Market

updated 9 hours ago Sponsored by:
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASD 4,683.92 -49.58 -1.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/4/2015 4:00 PM
RMD $51.17 Down -0.46 -0.89%
ResMed, Inc. CAPS Rating: ****